🟢 Inovio Pharmaceuticals is trading 5.5% up today amid sector-led biotech momentum

Inovio Pharmaceuticals is trading at $1.44, up 5.51%, with biotech sector momentum appearing to be the clearest explanation.

• No new company-specific catalyst was identified on September 3, 2026; the recent investor-conference announcement concerns events beginning September 9.
• XBI rose 2.75% during regular trading, supporting a sector-led move.
• The October 30, 2026 FDA decision for INO-3107 may support sentiment, but that regulatory milestone is not new.